Molina Healthcare (NYSE:MOH) Upgraded at ValuEngine

ValuEngine upgraded shares of Molina Healthcare (NYSE:MOH) from a strong sell rating to a sell rating in a research note issued to investors on Thursday morning, ValuEngine reports.

Several other equities analysts have also commented on MOH. Wells Fargo & Co raised Molina Healthcare from a market perform rating to an outperform rating and set a $177.00 price target on the stock in a research report on Friday, May 31st. Morgan Stanley boosted their price target on Molina Healthcare from $178.00 to $184.00 and gave the stock an overweight rating in a research report on Friday, July 12th. Stephens set a $150.00 price target on Molina Healthcare and gave the stock a hold rating in a research report on Wednesday. Bank of America reissued an underperform rating and set a $140.00 price target (up from $132.00) on shares of Molina Healthcare in a research report on Wednesday, July 31st. Finally, BMO Capital Markets raised Molina Healthcare from a market perform rating to an outperform rating and boosted their price target for the stock from $154.00 to $200.00 in a research report on Monday, June 3rd. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus price target of $163.36.

Shares of NYSE:MOH traded down $0.77 during trading on Thursday, reaching $134.44. 470,783 shares of the stock were exchanged, compared to its average volume of 524,423. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.73 and a current ratio of 1.73. Molina Healthcare has a 12-month low of $105.28 and a 12-month high of $159.00. The firm has a market capitalization of $8.47 billion, a price-to-earnings ratio of 12.13, a price-to-earnings-growth ratio of 1.22 and a beta of 1.25. The company has a 50-day moving average price of $139.67.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Tuesday, July 30th. The company reported $3.11 EPS for the quarter, topping the consensus estimate of $2.56 by $0.55. The firm had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.08 billion. Molina Healthcare had a return on equity of 51.49% and a net margin of 4.48%. Molina Healthcare’s revenue for the quarter was down 14.1% on a year-over-year basis. During the same period in the previous year, the company posted $3.08 EPS. On average, analysts expect that Molina Healthcare will post 11.48 earnings per share for the current fiscal year.

In other Molina Healthcare news, Director Garrey Carruthers sold 1,300 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $152.75, for a total value of $198,575.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Ronna Romney sold 375 shares of the company’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $131.63, for a total value of $49,361.25. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 5,679 shares of company stock worth $868,556. 0.77% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently made changes to their positions in the business. Iridian Asset Management LLC CT raised its position in shares of Molina Healthcare by 7.7% in the 1st quarter. Iridian Asset Management LLC CT now owns 1,139,103 shares of the company’s stock valued at $161,707,000 after purchasing an additional 81,120 shares in the last quarter. TCW Group Inc. increased its holdings in shares of Molina Healthcare by 8.8% in the 1st quarter. TCW Group Inc. now owns 635,639 shares of the company’s stock valued at $90,235,000 after acquiring an additional 51,384 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Molina Healthcare by 4.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 610,075 shares of the company’s stock valued at $70,899,000 after acquiring an additional 25,932 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Molina Healthcare by 5.3% in the 4th quarter. Geode Capital Management LLC now owns 586,758 shares of the company’s stock valued at $68,192,000 after acquiring an additional 29,687 shares during the last quarter. Finally, New York State Common Retirement Fund increased its holdings in shares of Molina Healthcare by 22.3% in the 1st quarter. New York State Common Retirement Fund now owns 389,143 shares of the company’s stock valued at $55,243,000 after acquiring an additional 70,912 shares during the last quarter. 99.94% of the stock is currently owned by institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Featured Story: How to start trading in the forex market?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.